Overview
Equal-risk-weighted alternative to market-cap US equity indexing. Stratifies the S&P 500 by business risk across 6 dimensions rather than market cap. Reduces FAANG/mega-cap concentration. More balanced sector exposure.
Top Holdings
| Ticker | Holding | Weight |
|---|---|---|
| JNJ | Johnson & Johnson | 2.4% |
| PG | Procter & Gamble | 2.2% |
| JPM | JPMorgan Chase | 2.0% |
| UNH | UnitedHealth Group | 1.9% |
| HD | Home Depot | 1.8% |
| XOM | Exxon Mobil | 1.8% |
| ABBV | AbbVie Inc. | 1.7% |
| CVX | Chevron Corp. | 1.7% |
| KO | Coca-Cola | 1.6% |
| MRK | Merck & Co. | 1.6% |
Fund Details
Investment Thesis
SAMT uses Syntax's proprietary stratification methodology to weight S&P 500 stocks by business risk rather than market capitalization. The methodology categorizes each company across six business dimensions — products, customers, suppliers, competitors, partners, and regulators — then weights them to achieve balanced risk exposure across each dimension. The result reduces the extreme mega-cap technology concentration of standard cap-weighted S&P 500 ETFs while maintaining diversified exposure to the same underlying companies. This provides a systematic way to own the S&P 500 without the concentration risk that has made VOO and SPY heavily FAANG-dependent.
Who It's For
Investors who want S&P 500 exposure without the extreme concentration in mega-cap technology stocks that market-cap weighting creates. SAMT suits those who believe equal-risk weighting provides better long-term risk-adjusted returns than cap-weighting when technology valuations are extended, and those who want more balanced sector exposure within US large-cap equity. Best used as an alternative or complement to standard cap-weighted S&P 500 funds.
10-Year History
| Year | Close | % Chg |
|---|---|---|
| 2016 | -- | -- |
| 2017 | -- | -- |
| 2018 | -- | -- |
| 2019 | $24.82 | -- |
| 2020 | $26.42 | +6.4% |
| 2021 | $34.82 | +31.8% |
| 2022 | $28.42 | -18.4% |
| 2023 | $34.42 | +21.1% |
| 2024 | $34.82 | +1.2% |
| 2025 | $39.98 | +14.8% |
| Year | Yield |
|---|---|
| 2016 | -- |
| 2017 | -- |
| 2018 | -- |
| 2019 | 1.22% |
| 2020 | 1.12% |
| 2021 | 1.02% |
| 2022 | 1.18% |
| 2023 | 1.08% |
| 2024 | 1.12% |
| 2025 | 1.22% |
| Year | AUM | % Chg |
|---|---|---|
| 2016 | -- | -- |
| 2017 | -- | -- |
| 2018 | -- | -- |
| 2019 | $0.1B | -- |
| 2020 | $0.2B | +100.0% |
| 2021 | $0.3B | +50.0% |
| 2022 | $0.3B | 0.0% |
| 2023 | $0.3B | 0.0% |
| 2024 | $0.3B | 0.0% |
| 2025 | $0.32B | +6.7% |
Historical figures are ETFHub estimates modelled from asset-class return patterns and may differ from official fund records. Data as of August 2026.
Related US Broad Market ETFs
Markets. Intelligence. Daily.
Full briefs on 251 ETFs, curated daily ETF news, and a free weekly deep-dive newsletter — all on ETFHub.
Get the Free Weekly Brief Explore the ETF Portal Official Fund Page →